Ionis Pharmaceuticals IONS Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's other accrued liabilities?
- Ionis Pharmaceuticals (IONS) reported other accrued liabilities of $23.39M in Q1 2026.
- How has Ionis Pharmaceuticals's other accrued liabilities changed year-over-year?
- Ionis Pharmaceuticals's other accrued liabilities increased by 4.9% year-over-year, from $22.3M to $23.39M.
- What is the long-term trend for Ionis Pharmaceuticals's other accrued liabilities?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's other accrued liabilities has grown at a 59.4% compound annual growth rate (CAGR), from $3.53M to $22.74M.